申请人:Jolidon Synese
公开号:US20060167009A1
公开(公告)日:2006-07-27
The present invention relates to compounds of formula I
wherein
R
1
,
R
2
, X
1
, and X
2
are as defined in the specification and to pharmaceutically acceptable acid addition salts thereof. Such compounds are inhibitors of the glycine transporter 1 (GlyT-1) and can be used in the treatment of schizophrenia, cognitive impairment, and Alzheimer's disease.
本发明涉及公式I的化合物,其中R1,R2,X1和X2的定义如规范中所述,以及其药学上可接受的酸盐。这些化合物是甘氨酸转运体1(GlyT-1)的抑制剂,可用于治疗精神分裂症、认知障碍和阿尔茨海默病。